Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 19 | 2021 | 210 | 3.340 |
Why?
|
| Learning | 10 | 2017 | 161 | 1.480 |
Why?
|
| Motor Skills | 4 | 2021 | 46 | 1.410 |
Why?
|
| Motor Cortex | 6 | 2017 | 54 | 1.150 |
Why?
|
| Dystonia | 4 | 2022 | 12 | 1.090 |
Why?
|
| Psychomotor Performance | 14 | 2017 | 159 | 1.060 |
Why?
|
| Neuronal Plasticity | 4 | 2022 | 126 | 0.970 |
Why?
|
| Dystonic Disorders | 3 | 2022 | 8 | 0.950 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2022 | 25 | 0.710 |
Why?
|
| Beta Rhythm | 1 | 2021 | 2 | 0.700 |
Why?
|
| Hypokinesia | 1 | 2021 | 4 | 0.700 |
Why?
|
| Brain | 9 | 2020 | 1472 | 0.650 |
Why?
|
| Reaction Time | 7 | 2015 | 157 | 0.550 |
Why?
|
| Electroencephalography | 4 | 2015 | 139 | 0.540 |
Why?
|
| Parietal Lobe | 2 | 2014 | 10 | 0.510 |
Why?
|
| Frontal Lobe | 3 | 2016 | 58 | 0.510 |
Why?
|
| Temperature | 1 | 2017 | 313 | 0.460 |
Why?
|
| Aging | 2 | 2015 | 783 | 0.430 |
Why?
|
| Movement | 6 | 2017 | 119 | 0.410 |
Why?
|
| Molecular Chaperones | 4 | 2011 | 70 | 0.390 |
Why?
|
| Memory, Short-Term | 1 | 2013 | 59 | 0.390 |
Why?
|
| Exercise | 1 | 2017 | 692 | 0.340 |
Why?
|
| Motor Activity | 6 | 2016 | 437 | 0.310 |
Why?
|
| Cerebellum | 6 | 2017 | 79 | 0.310 |
Why?
|
| Humans | 38 | 2022 | 43102 | 0.300 |
Why?
|
| Middle Aged | 25 | 2019 | 12222 | 0.300 |
Why?
|
| Levodopa | 4 | 2017 | 26 | 0.290 |
Why?
|
| Aged | 19 | 2018 | 8214 | 0.290 |
Why?
|
| Male | 30 | 2019 | 23409 | 0.270 |
Why?
|
| Female | 29 | 2019 | 24698 | 0.250 |
Why?
|
| Huntington Disease | 3 | 2016 | 31 | 0.250 |
Why?
|
| Photic Stimulation | 5 | 2015 | 125 | 0.230 |
Why?
|
| Serial Learning | 3 | 2012 | 5 | 0.230 |
Why?
|
| Brain Mapping | 7 | 2019 | 137 | 0.230 |
Why?
|
| Theta Rhythm | 2 | 2015 | 11 | 0.210 |
Why?
|
| Neural Pathways | 3 | 2020 | 138 | 0.210 |
Why?
|
| Psychomotor Disorders | 1 | 2003 | 9 | 0.200 |
Why?
|
| Point Mutation | 1 | 2003 | 98 | 0.200 |
Why?
|
| Tomography, Emission-Computed | 6 | 2004 | 13 | 0.190 |
Why?
|
| Transcranial Magnetic Stimulation | 5 | 2015 | 14 | 0.190 |
Why?
|
| Long-Term Potentiation | 3 | 2007 | 109 | 0.190 |
Why?
|
| Fatigue | 2 | 2015 | 100 | 0.180 |
Why?
|
| Carrier Proteins | 2 | 2004 | 321 | 0.180 |
Why?
|
| Cognition | 2 | 2019 | 473 | 0.170 |
Why?
|
| Electromyography | 2 | 2022 | 69 | 0.170 |
Why?
|
| Space Perception | 2 | 2011 | 35 | 0.170 |
Why?
|
| Rest | 3 | 2019 | 32 | 0.170 |
Why?
|
| Neuropsychological Tests | 5 | 2016 | 284 | 0.160 |
Why?
|
| Nerve Net | 3 | 2015 | 101 | 0.160 |
Why?
|
| Antiparkinson Agents | 2 | 2019 | 14 | 0.160 |
Why?
|
| Cerebral Cortex | 3 | 2007 | 306 | 0.160 |
Why?
|
| Exercise Therapy | 2 | 2018 | 87 | 0.150 |
Why?
|
| Muscle, Skeletal | 2 | 2022 | 316 | 0.140 |
Why?
|
| Sleep Deprivation | 2 | 2017 | 28 | 0.140 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2017 | 16 | 0.130 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2017 | 8 | 0.130 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2017 | 27 | 0.130 |
Why?
|
| Deep Brain Stimulation | 2 | 2020 | 17 | 0.130 |
Why?
|
| Visual Pathways | 1 | 2017 | 40 | 0.130 |
Why?
|
| Evoked Potentials, Motor | 3 | 2016 | 22 | 0.130 |
Why?
|
| Vision Disorders | 1 | 2017 | 61 | 0.130 |
Why?
|
| Functional Laterality | 3 | 2006 | 89 | 0.120 |
Why?
|
| Adult | 13 | 2016 | 13872 | 0.110 |
Why?
|
| Basal Ganglia | 1 | 2015 | 21 | 0.110 |
Why?
|
| Wakefulness | 1 | 2015 | 24 | 0.110 |
Why?
|
| Sleep | 1 | 2017 | 185 | 0.110 |
Why?
|
| Cognition Disorders | 1 | 2016 | 243 | 0.110 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 50 | 0.110 |
Why?
|
| Dopamine | 2 | 2008 | 275 | 0.110 |
Why?
|
| Anxiety | 1 | 2022 | 874 | 0.100 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 1001 | 0.100 |
Why?
|
| Alpha Rhythm | 1 | 2013 | 5 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2016 | 1285 | 0.100 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2013 | 81 | 0.100 |
Why?
|
| Quality of Life | 1 | 2018 | 616 | 0.100 |
Why?
|
| Subthalamic Nucleus | 1 | 2012 | 15 | 0.090 |
Why?
|
| Proprioception | 1 | 2011 | 9 | 0.090 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2010 | 2 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2019 | 587 | 0.080 |
Why?
|
| Blinking | 2 | 2007 | 14 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 161 | 0.080 |
Why?
|
| Factor Analysis, Statistical | 1 | 2010 | 162 | 0.080 |
Why?
|
| Corpus Striatum | 2 | 2017 | 121 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2010 | 317 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 440 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 333 | 0.070 |
Why?
|
| Positron-Emission Tomography | 4 | 2012 | 93 | 0.070 |
Why?
|
| Young Adult | 3 | 2015 | 5080 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2007 | 58 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 561 | 0.070 |
Why?
|
| Heterozygote | 2 | 2007 | 110 | 0.070 |
Why?
|
| Brain Stem | 1 | 2007 | 52 | 0.070 |
Why?
|
| Down Syndrome | 1 | 2007 | 32 | 0.060 |
Why?
|
| Trigeminal Nerve | 1 | 2006 | 32 | 0.060 |
Why?
|
| Analysis of Variance | 4 | 2012 | 575 | 0.060 |
Why?
|
| Synaptic Transmission | 1 | 2007 | 149 | 0.060 |
Why?
|
| Imagination | 1 | 2006 | 9 | 0.060 |
Why?
|
| Mutation | 1 | 2011 | 1177 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 719 | 0.060 |
Why?
|
| Prefrontal Cortex | 2 | 2004 | 164 | 0.060 |
Why?
|
| Perception | 1 | 2006 | 215 | 0.050 |
Why?
|
| Caudate Nucleus | 1 | 2004 | 22 | 0.050 |
Why?
|
| Dystonia Musculorum Deformans | 1 | 2004 | 1 | 0.050 |
Why?
|
| Depression | 1 | 2011 | 863 | 0.050 |
Why?
|
| Arousal | 1 | 2004 | 95 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2004 | 100 | 0.050 |
Why?
|
| Random Allocation | 1 | 2003 | 147 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 224 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2003 | 143 | 0.050 |
Why?
|
| Electric Stimulation Therapy | 1 | 2002 | 18 | 0.050 |
Why?
|
| Globus Pallidus | 1 | 2002 | 21 | 0.050 |
Why?
|
| Parkinsonian Disorders | 1 | 2002 | 42 | 0.050 |
Why?
|
| Muscle Rigidity | 1 | 2022 | 2 | 0.050 |
Why?
|
| Stroke | 1 | 2006 | 340 | 0.040 |
Why?
|
| Glucose | 1 | 2003 | 244 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 386 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2018 | 54 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2007 | 39 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2017 | 14 | 0.030 |
Why?
|
| Electric Stimulation | 2 | 2007 | 186 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2016 | 67 | 0.030 |
Why?
|
| Gyrus Cinguli | 1 | 2016 | 31 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 611 | 0.030 |
Why?
|
| Volition | 1 | 2015 | 9 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 1600 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 1081 | 0.030 |
Why?
|
| Hippocampus | 1 | 2017 | 594 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 1604 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2012 | 70 | 0.020 |
Why?
|
| Mental Recall | 1 | 2012 | 84 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 2011 | 18 | 0.020 |
Why?
|
| Arm | 1 | 2011 | 28 | 0.020 |
Why?
|
| Hand | 1 | 2011 | 34 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 123 | 0.020 |
Why?
|
| Demography | 1 | 2011 | 195 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 2853 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 490 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 712 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 800 | 0.020 |
Why?
|
| Median Nerve | 1 | 2007 | 5 | 0.020 |
Why?
|
| Neural Conduction | 1 | 2007 | 17 | 0.020 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2007 | 9 | 0.020 |
Why?
|
| Mice | 1 | 2017 | 6644 | 0.010 |
Why?
|
| Kinesthesis | 1 | 2004 | 3 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 2004 | 10 | 0.010 |
Why?
|
| Tropanes | 1 | 2004 | 7 | 0.010 |
Why?
|
| Fluorine Radioisotopes | 1 | 2004 | 12 | 0.010 |
Why?
|
| Putamen | 1 | 2004 | 16 | 0.010 |
Why?
|
| Thalamus | 1 | 2004 | 34 | 0.010 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2004 | 59 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2004 | 17 | 0.010 |
Why?
|
| Receptors, Dopamine | 1 | 2004 | 30 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2004 | 62 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 2003 | 47 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2003 | 174 | 0.010 |
Why?
|
| Binding Sites | 1 | 2004 | 671 | 0.010 |
Why?
|
| Animals | 1 | 2017 | 16992 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 1857 | 0.010 |
Why?
|
| Adolescent | 1 | 2007 | 6081 | 0.010 |
Why?
|